Laura Spring, MD
Massachusetts General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Laura Spring, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:40 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04230109 · Sacituzumab Govitecan In TNBCMassachusetts General Hospital · recruiting · Invasive Breast Cancer, Triple Negative Breast Cancer, ER-Negative Breast Cancer · principal investigator
- Ph1/Ph2NCT04039230 · Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.Massachusetts General Hospital · active not recruiting · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.